Dalacin C Phosphate en es it fr

Dalacin C Phosphate Brand names, Dalacin C Phosphate Analogs

Dalacin C Phosphate Brand Names Mixture

  • No information avaliable

Dalacin C Phosphate Chemical_Formula

C18H33ClN2O5S

Dalacin C Phosphate RX_link

http://www.rxlist.com/cgi/generic2/clindam.htm

Dalacin C Phosphate fda sheet

Dalacin_C_Phosphate FDA

Dalacin C Phosphate msds (material safety sheet)

Dalacin C Phosphate Synthesis Reference

Birkenmeyer, U.S. Pat. 3,475,407(1970)

Dalacin C Phosphate Molecular Weight

424.984 g/mol

Dalacin C Phosphate Melting Point

255 oC

Dalacin C Phosphate H2O Solubility

30.6 mg/L

Dalacin C Phosphate State

Solid

Dalacin C Phosphate LogP

1.224

Dalacin C Phosphate Dosage Forms

Capsules; Intramuscular solution; Intravenousparenteral solution; Topical solution; Topical lotion; Topical gel; Vaginal cream; Vaginal ovules

Dalacin C Phosphate Indication

For the treatment of serious infections caused by susceptible anaerobic bacteria (anaerobes, streptococci, pneumococci, and staphylococci)

Dalacin C Phosphate Pharmacology

Clindamycin is an antibiotic, similar to and a derivative of lincomycin. Clindamycin can be used in topical or systemic treatment. It is effective as an anti-anaerobic antibiotic and antiprotozoal.

Dalacin C Phosphate Absorption

- 90% - oral

Dalacin C Phosphate side effects and Toxicity

Orally and parenterally administered clindamycin has been associated with severe colitis (pseudomembranous colitis) which may result in patient death. Use of the topical formulation of clindamycin results in absorption of the antibiotic from the skin surface. Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been reported with the use of topical and systemic clindamycin.

Dalacin C Phosphate Patient Information

Dalacin C Phosphate Organisms Affected

Enteric bacteria and other eubacteria